Search - tctmd.com

Displaying 1 - 20 of 49

Sort: Relevancy | Date

News Daily News

Top Coronary Artery Disease News of 2023

Michael O'Riordan

December 22, 2023

News Daily News

Short DAPT May Be Especially Beneficial for Women at High Bleeding Risk

Yael L. Maxwell

November 30, 2023

News Daily News

Guiding DAPT Based on Genes or Platelet Tests Still ‘Tempting’

Yael L. Maxwell

November 08, 2023

News Conference News TCT 2023

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

Michael O'Riordan

November 01, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2023

Shelley Wood

November 01, 2023

News Conference News TCT 2023

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

L.A. McKeown

October 31, 2023

Presentation TCT 2023

TCT 781: Clinical outcomes of patients treated using 1-month dual antiplatelet therapy after biodegradable-polymer DES implantation

Presenter: Masaru Ishida

October 26, 2023

Presentation TCT 2023

TCT 406: Effect of Antithrombotic Strategies on Total Outcome Events in Patients with Atrial Fibrillation after Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights from AUGUSTUS

Presenter: Manasi Tannu

October 26, 2023

Presentation TCT 2023

TCT 215: Safety of Bivalirudin Versus Heparin in Patients With ST-elevation Myocardial Infarction: a Systematic Review and Meta-analysis:

Presenter: Mostafa Elbanna

October 26, 2023

Presentation TCT 2023

TCT 174: The Impact of Pre-Hospital Statin Therapy on Cardiovascular Events in STEMI Patients without a History of Revascularization: Insights from the TWINCRE Registry

Presenter: KEI INUTSUKA

October 26, 2023

Presentation TCT 2023

TCT 165: Aspirin-Free Prasugrel Monotherapy: Thirty Days Clinical Outcome after Percutaneous Coronary Intervention in Chronic Coronary Syndrome and Non-ST Segment Elevation Acute Coronary Syndrome

Presenter: Gaku Nakazawa

October 26, 2023

Presentation TCT 2023

TCT 706: 3-6 Month vs 12 Month Dual Antiplatelet Therapy After Drug Eluting Stent Placement: An Updated Meta-Analysis

Presenter: Aakash Garg

October 25, 2023

Presentation TCT 2023

TCT 659: De-escalation of antiplatelet therapy in elderly or low-weight patients with myocardial infarction.

Presenter: Hyunki LEE

October 25, 2023

Presentation TCT 2023

TCT 381: The Clinical implementation of CYP2C19 genotyping in patients with an acute coronary syndrome: Insights from the FORCE-ACS registry

Presenter: Jaouad Azzahhafi

October 25, 2023

Presentation TCT 2023

TCT 135: Ticagrelor Coated Stent to Eliminate the Need for DAPT post-PCI

Presenter: Jared Romeo

October 25, 2023

Presentation TCT 2023

TCT 99: Efficacy and safety of early single direct oral anticoagulant therapy within one year after coronary stent implantation in patients with atrial fibrillation

Presenter: Taehoon Kim

October 25, 2023

Presentation TCT 2023

TCT 11: Clinical impact of dyspnea after ticagrelor treatment and the effect of switching to clopidogrel in patients with myocardial infarction

Presenter: Sang Hyun Kim

October 25, 2023

Presentation TCT 2023

TCT 657: Aspirin versus P2Y12 inhibitor as a combination therapy with direct oral anticoagulant after coronary stent implantation in patients with atrial fibrillation (AF).

Presenter: Hyunki LEE

October 25, 2023

Presentation TCT 2023

TCT 525: The Prevalence of Bleeding and Ischemic Outcomes in Patients on Triple Therapy in a Real-Practice Registry of Percutaneous Coronary Interventions

Presenter: Eva Woelders

October 25, 2023

Presentation TCT 2023

TCT 507: Association of CYP2C19*17 Carrier Status to Ischemic and Bleeding Outcomes Among Patients with Coronary Artery Disease Treated with Clopidogrel: a Meta-Analysis

Presenter: Cole Clifford

October 25, 2023

Advertisement

Top Coronary Artery Disease News of 2023

Short DAPT May Be Especially Beneficial for Women at High Bleeding Risk

Guiding DAPT Based on Genes or Platelet Tests Still ‘Tempting’

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

TCTMD’s Top 10 Most Popular Stories for October 2023

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

TCT 781: Clinical outcomes of patients treated using 1-month dual antiplatelet therapy after biodegradable-polymer DES implantation

TCT 406: Effect of Antithrombotic Strategies on Total Outcome Events in Patients with Atrial Fibrillation after Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights from AUGUSTUS

TCT 215: Safety of Bivalirudin Versus Heparin in Patients With ST-elevation Myocardial Infarction: a Systematic Review and Meta-analysis:

TCT 174: The Impact of Pre-Hospital Statin Therapy on Cardiovascular Events in STEMI Patients without a History of Revascularization: Insights from the TWINCRE Registry

TCT 165: Aspirin-Free Prasugrel Monotherapy: Thirty Days Clinical Outcome after Percutaneous Coronary Intervention in Chronic Coronary Syndrome and Non-ST Segment Elevation Acute Coronary Syndrome

TCT 706: 3-6 Month vs 12 Month Dual Antiplatelet Therapy After Drug Eluting Stent Placement: An Updated Meta-Analysis

TCT 659: De-escalation of antiplatelet therapy in elderly or low-weight patients with myocardial infarction.

TCT 381: The Clinical implementation of CYP2C19 genotyping in patients with an acute coronary syndrome: Insights from the FORCE-ACS registry

TCT 135: Ticagrelor Coated Stent to Eliminate the Need for DAPT post-PCI

TCT 99: Efficacy and safety of early single direct oral anticoagulant therapy within one year after coronary stent implantation in patients with atrial fibrillation

TCT 11: Clinical impact of dyspnea after ticagrelor treatment and the effect of switching to clopidogrel in patients with myocardial infarction

TCT 657: Aspirin versus P2Y12 inhibitor as a combination therapy with direct oral anticoagulant after coronary stent implantation in patients with atrial fibrillation (AF).

TCT 525: The Prevalence of Bleeding and Ischemic Outcomes in Patients on Triple Therapy in a Real-Practice Registry of Percutaneous Coronary Interventions

TCT 507: Association of CYP2C19*17 Carrier Status to Ischemic and Bleeding Outcomes Among Patients with Coronary Artery Disease Treated with Clopidogrel: a Meta-Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content